Jove
Visualize
Contáctanos
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Videos de Conceptos Relacionados

Viral Mutations00:36

Viral Mutations

32.1K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
32.1K
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

732
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
732
Diversity of Antigen Receptors01:28

Diversity of Antigen Receptors

495
Antigen receptors are essential components of the immune system crucial in defending the body against foreign invaders. These receptors are present on the surface of B and T cells, enabling them to recognize antigens and mount an appropriate immune response.
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
495
Mutation, Gene Flow, and Genetic Drift01:09

Mutation, Gene Flow, and Genetic Drift

57.9K
In a population that is not at Hardy-Weinberg equilibrium, the frequency of alleles changes over time. Therefore, any deviations from the five conditions of Hardy-Weinberg equilibrium can alter the genetic variation of a given population. Conditions that change the genetic variability of a population include mutations, natural selection, non-random mating, gene flow, and genetic drift (small population size).
57.9K
Antigens Involved in Adaptive Immunity01:26

Antigens Involved in Adaptive Immunity

446
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
446
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

13.9K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
13.9K

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

Reduction in Respiratory Syncytial Virus (RSV)-Related Outpatient and Inpatient Cases Among Infants During the Initial 2024/2025 Season Following Nirsevimab Recommendation in Germany.

Influenza and other respiratory viruses·2026
Same author

Endothelial glycocalyx perturbation in obstructive sleep apnea is associated with repetitive hypoxemia and immunothrombotic endothelial dysfunction.

Journal of translational medicine·2026
Same author

Monitoring viral evolution and epidemiological characteristics of SARS-CoV-2 during 2022-2023 using Integrated Genomic Surveillance.

Communications medicine·2026
Same author

Author Correction: Pharmacological markers of HIV prevention for oral pre-exposure prophylaxis in men who have sex with men.

Nature communications·2026
Same author

Pharmacological markers of HIV prevention for oral pre-exposure prophylaxis in men who have sex with men.

Nature communications·2026
Same author

Historical Pandemic and Contemporary Influenza A Viruses Reveal PB2 M631L as a Convergent Adaptation to Human ANP32.

Microorganisms·2026

Video Experimental Relacionado

Updated: May 30, 2025

Visualization of SARS-CoV-2 using Immuno RNA-Fluorescence In Situ Hybridization
05:23

Visualization of SARS-CoV-2 using Immuno RNA-Fluorescence In Situ Hybridization

Published on: December 23, 2020

6.0K

La evolución del SARS-CoV-2 en un paisaje inmune dinámico

N Alexia Raharinirina1, Nils Gubela1,2, Daniela Börnigen3

  • 1Department of Mathematics & Computer Science, Freie Universität Berlin, Berlin, Germany.

Nature
|January 29, 2025
PubMed
Resumen
Este resumen es generado por máquina.

El virus SARS-CoV-2 evoluciona para evadir los anticuerpos, impulsado por la inmunidad de la población moldeada por el historial de infección. Nuestro modelo predice con precisión la propagación y la aptitud de la variante, ayudando a la evaluación del riesgo y al diseño de la vacuna.

Más Videos Relacionados

Detection of SARS-CoV-2 Neutralizing Antibodies using High-Throughput Fluorescent Imaging of Pseudovirus Infection
10:25

Detection of SARS-CoV-2 Neutralizing Antibodies using High-Throughput Fluorescent Imaging of Pseudovirus Infection

Published on: June 5, 2021

4.5K
Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
08:41

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2

Published on: November 5, 2021

2.7K

Videos de Experimentos Relacionados

Last Updated: May 30, 2025

Visualization of SARS-CoV-2 using Immuno RNA-Fluorescence In Situ Hybridization
05:23

Visualization of SARS-CoV-2 using Immuno RNA-Fluorescence In Situ Hybridization

Published on: December 23, 2020

6.0K
Detection of SARS-CoV-2 Neutralizing Antibodies using High-Throughput Fluorescent Imaging of Pseudovirus Infection
10:25

Detection of SARS-CoV-2 Neutralizing Antibodies using High-Throughput Fluorescent Imaging of Pseudovirus Infection

Published on: June 5, 2021

4.5K
Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
08:41

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2

Published on: November 5, 2021

2.7K

Área de la Ciencia:

  • Virología
  • Epidemiología
  • Inmunología

Sus antecedentes:

  • El surgimiento de variantes del SARS-CoV-2 con proteínas de pico mutadas plantea desafíos para neutralizar los anticuerpos.
  • Se hipotetiza que la evolución viral es impulsada por la necesidad de evadir la inmunidad existente de la población de las vacunas o infecciones previas.

Objetivo del estudio:

  • Desarrollar un modelo mecanicista que prediga poblaciones susceptibles específicas de la variante a lo largo del tiempo.
  • Para entender cómo la evolución viral navega un paisaje inmune dinámico moldeado por la historia de la infección local.

Principales métodos:

  • Datos integrados de exploración mutativa profunda, farmacocinética de anticuerpos y vigilancia genómica regional.
  • Desarrolló un modelo mecanicista integral para predecir la dinámica de las variantes.

Principales resultados:

  • El modelo coincidía con la dinámica histórica de las variantes a nivel mundial.
  • El modelo predijo con éxito la propagación futura de la variante y explicó las variaciones internacionales en la prevalencia de la variante.
  • Demostró que la inmunidad de la población determina significativamente la aptitud y la transmisión de la variante.

Conclusiones:

  • La dinámica pandémica en curso altera continuamente la inmunidad de la población, lo que influye en la transmisión y la aptitud de la variante del SARS-CoV-2.
  • El modelo desarrollado ofrece una herramienta para la evaluación regional del riesgo de las variantes e informa sobre las estrategias de diseño de vacunas.